Join
Live feed
·
INSIDERFilingvia Quantisnow
Veracyte Inc. logo

Director Eastham Karin sold $197,234 worth of shares (3,729 units at $52.89) as part of a pre-agreed trading plan, decreasing direct ownership by 20% to 15,097 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
VCYT· Veracyte Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VCYT (Veracyte Inc.) and more on Quantisnow.